Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Weight Loss D015431 56 associated lipids
Endotoxemia D019446 27 associated lipids
Blister D001768 16 associated lipids
Memory Disorders D008569 33 associated lipids
Acute Lung Injury D055371 33 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Granulomatosis with Polyangiitis D014890 5 associated lipids
Lupus Nephritis D008181 8 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Ileal Diseases D007077 3 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Rink TJ Stimulus-response coupling mechanisms in human platelets. 1986 Agents Actions Suppl. pmid:3028101
Baroggi N et al. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds. 1986 Agents Actions Suppl. pmid:3028108
Bush LR and Smith SG Antagonism of U46619-induced aggregation of human and canine platelets by four TXA2 receptor antagonists. 1986 Thromb. Res. pmid:2948294
Valone FH and Ruis NM Platelet-activating factor binding to human platelet membranes. 1986 Biotechnol. Appl. Biochem. pmid:3021183
Braquet P Proofs of involvement of PAF-acether in various immune disorders using BN 52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo biloba L. 1986 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2949548
Naccache PH et al. Biochemical events associated with the stimulation of rabbit neutrophils by platelet-activating factor. 1986 J. Leukoc. Biol. pmid:3021882
Chamone DF et al. Increased levels of eosinophil-derived PAF-acether activity in a patient with idiopathic hypereosinophilic syndrome. 1986 Braz. J. Med. Biol. Res. pmid:3801724
Toth PD and Mikulaschek AW Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat. 1986 Circ. Shock pmid:3802423
Desquand S et al. Interference of BN 52021 (ginkgolide B) with the bronchopulmonary effects of PAF-acether in the guinea-pig. 1986 Eur. J. Pharmacol. pmid:3019727
Daniel LW et al. A novel mechanism of diglyceride formation. 12-O-tetradecanoylphorbol-13-acetate stimulates the cyclic breakdown and resynthesis of phosphatidylcholine. 1986 J. Biol. Chem. pmid:3087989
Coëffier E et al. Effects of PAF-acether and structural analogues on platelet activation and bronchoconstriction in guinea-pigs. 1986 Eur. J. Pharmacol. pmid:3816952
Schlondorff D and Neuwirth R Platelet-activating factor and the kidney. 1986 Am. J. Physiol. pmid:3089026
Oda M et al. Polymorphonuclear leukocyte-platelet interactions: acetylglyceryl ether phosphocholine-induced platelet activation under stimulation with chemotactic peptide. 1986 J. Biochem. pmid:3818574
Nishihira J and Ishibashi T A phospholipase C with a high specificity for platelet-activating factor in rabbit liver light mitochondria. 1986 Lipids pmid:3821393
Lauri D et al. Contribution of ADP to the amplification of primary platelet aggregation by platelet activating factor (PAF): modulatory role of aspirin. 1986 Agents Actions pmid:3706054
Nijssen JG et al. Identification of a calcium-independent phospholipase A2 in rat lung cytosol and differentiation from acetylhydrolase for 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (PAF-acether). 1986 Biochim. Biophys. Acta pmid:3707986
Kloprogge E et al. Stimulus-aggregation coupling in platelets activated with PAF-acether. 1986 Biochim. Biophys. Acta pmid:3089297
Lynch JM and Henson PM The intracellular retention of newly synthesized platelet-activating factor. 1986 J. Immunol. pmid:3093579
McMurtry IF and Morris KG Platelet-activating factor causes pulmonary vasodilation in the rat. 1986 Am. Rev. Respir. Dis. pmid:3094417
Issekutz AC and Ripley M The effect of intravascular neutrophil chemotactic factors on blood neutrophil and platelet kinetics. 1986 Am. J. Hematol. pmid:2934975
Alexandre A et al. Inhibition by antioxidants of agonist evoked cytosolic Ca++ increase, ATP secretion and aggregation of aspirinated human platelets. 1986 Biochem. Biophys. Res. Commun. pmid:3094518
Alam I and Silver MJ Acetyltransferase activity in human platelet microsomes and washed platelets. 1986 Biochim. Biophys. Acta pmid:3094588
Viero P et al. Thrombotic thrombocytopenic purpura and high-dose immunoglobulin treatment. 1986 Ann. Intern. Med. pmid:3946966
Siafaka-Kapadai A et al. Biological activity of lipids of pine pollen on platelet aggregation in correlation with the platelet activating factor. 1986 Biochem. Int. pmid:3947373
McNamara PJ et al. Autacoid binding to serum proteins. Interaction of platelet activating factor (PAF) with human serum alpha-1-acid glycoprotein (AAG). 1986 Biochem. Pharmacol. pmid:3947392
Morley J Platelet activating factor and asthma. 1986 Agents Actions pmid:3099555
Orchard MA et al. Basophil histamine release induced by a substance from stimulated human platelets. 1986 J. Immunol. pmid:2419428
Anderson RC et al. Platelet-activating factor analogs. II. Synthesis of the 1-O-(4-decyloxymethylphenyl)- and 1-O-(4-decyloxyphenylmethyl) analogs. 1986 Chem. Phys. Lipids pmid:3948294
Tselepis A et al. Effects of AGEPC on the intracellular levels of ions in Tetrahymena pyriformis. 1986 Biochem. Int. pmid:3099798
Hwang SB et al. Release of platelet activating factor and its involvement in the first phase of carrageenin-induced rat foot edema. 1986 Eur. J. Pharmacol. pmid:3948914
Doyle VM et al. Platelet-activating factor mobilizes intracellular calcium in vascular smooth muscle cells. 1986 FEBS Lett. pmid:3949010
Patscheke H and Dierichs R Cationized ferritin as a platelet-stimulating surface probe. Binding to platelets and effects on platelet function. 1986 Eur. J. Cell Biol. pmid:3084260
Billah MM et al. Metabolism of platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) by human promyelocytic leukemic HL60 cells. Stimulated expression of phospholipase A2 and acetyltransferase requires differentiation. 1986 J. Biol. Chem. pmid:3084473
Piper PJ and Stewart AG Coronary vasoconstriction in the rat, isolated perfused heart induced by platelet-activating factor is mediated by leukotriene C4. 1986 Br. J. Pharmacol. pmid:3091131
Hanahan DJ Platelet activating factor: a biologically active phosphoglyceride. 1986 Annu. Rev. Biochem. pmid:3017194
Bette-Bobillo P et al. Interaction between blood components and a spin-labeled analogue of PAF-acether. 1986 Biochim. Biophys. Acta pmid:3017416
Levesque JP et al. Fibrinogen mitogenic effect on hemopoietic cell lines: control via receptor modulation. 1986 Proc. Natl. Acad. Sci. U.S.A. pmid:3018735
Raaijmakers JA et al. Phospholipase A2 products induce pulmonary beta-adrenoceptor deviations. 1986 Eur. J. Pharmacol. pmid:3019725
Foegh ML et al. Fatty acids and eicosanoids in organ transplantation. 1986 Prog. Lipid Res. pmid:3321095
Satoh K and Takamatsu S [Inactivation by plasma of platelet-activating factor]. 1986 Nippon Ketsueki Gakkai Zasshi pmid:3766067
Gordeev KIu et al. [Synthesis of thioanalogs of platelet activating factor (PAF)]. 1986 Bioorg. Khim. pmid:3768051
Hoffman DR et al. Metabolism and function of platelet-activating factor in fetal rabbit lung development. 1986 Biochim. Biophys. Acta pmid:3768390
Okamoto M et al. Studies of platelet activating factor (PAF) antagonists from microbial products. III. Pharmacological studies of FR-900452 in animal models. 1986 Chem. Pharm. Bull. pmid:3769104
Ohga Y and Nakanishi M Stopped-flow spectrophotometry monitoring the initial processes of platelet activation by platelet-activating factor. 1986 FEBS Lett. pmid:3770190
Patterson R et al. Inhibition of rhesus monkey airway and cutaneous responses to platelet-activating factor (PAF) (AGEPC) with the anti-PAF agent SRI 63-072. 1986 Int. Arch. Allergy Appl. Immunol. pmid:3770978
Hsueh W et al. Release of leukotriene C4 by isolated, perfused rat small intestine in response to platelet-activating factor. 1986 J. Clin. Invest. pmid:3459734
Thomas Y et al. [Synthesis of paf-acether by E. coli K12]. 1986 C. R. Acad. Sci. III, Sci. Vie pmid:3101984
Cordeiro RS et al. Salicylates inhibit PAF-acether-induced rat paw oedema when cyclooxygenase inhibitors are ineffective. 1986 Prostaglandins pmid:3103172
Hwang SB et al. Ionic and GTP regulation of binding of platelet-activating factor to receptors and platelet-activating factor-induced activation of GTPase in rabbit platelet membranes. 1986 J. Biol. Chem. pmid:3001070
Buxton DB et al. Platelet-activating factor-mediated vasoconstriction and glycogenolysis in the perfused rat liver. 1986 J. Biol. Chem. pmid:3001074